Clinical Trial Update: Serum Histone Succinylation as a Novel Prognostic Biomarker in Hematological Malignancies

View source ↗

Summary

A clinical trial update evaluating serum histone succinylation as a prognostic biomarker in hematological malignancies, including leukemia and lymphoma, with re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leukemia
• Lymphoma

Snippet

Sponsor: The First Affiliated Hospital of Xinxiang Medical College | Conditions: Leukemia, Lymphoma | Status: NOT_YET_RECRUITING